Skip to content
10-Q

Quarterly Report

Marker Therapeutics, Inc. MRKR

0001410578-25-001826

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 12.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 13.96M sh
Shares Diluted Q2 2025 · Jun 30, 2025 12.54M sh
Shares Diluted Q2 2025 · Jun 30, 2024 8.92M sh
Shares Diluted Q2 2025 · Jun 30, 2024 8.91M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$7.38M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7.4M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $10.46M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $19.19M
Stockholders Equity Q2 2025 · Jun 30, 2025 $10.49M
Stockholders Equity Q2 2025 · Mar 31, 2025 $14.49M
Stockholders Equity Q2 2025 · Dec 31, 2024 $18.56M
Stockholders Equity Q2 2025 · Jun 30, 2024 $9.7M
Stockholders Equity Q2 2025 · Mar 31, 2024 $11.79M
Stockholders Equity Q2 2025 · Dec 31, 2023 $14.05M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.28M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.46M
Total Liabilities Q2 2025 · Jun 30, 2025 $4.28M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.46M
Current Assets Q2 2025 · Jun 30, 2025 $14.77M
Current Assets Q2 2025 · Dec 31, 2024 $22.02M
Total Assets Q2 2025 · Jun 30, 2025 $14.77M
Total Assets Q2 2025 · Dec 31, 2024 $22.02M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.29
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.67
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.25
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$0.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.67
Eps Basic Q2 2025 · Jun 30, 2024 −$0.25
Eps Basic Q2 2025 · Jun 30, 2024 −$0.51
Sga Expense Q2 2025 · Jun 30, 2025 $945.16K
Sga Expense Q2 2025 · Jun 30, 2025 $2.31M
Sga Expense Q2 2025 · Jun 30, 2024 $1.14M
Sga Expense Q2 2025 · Jun 30, 2024 $2.36M
Rd Expense Q2 2025 · Jun 30, 2025 $4.18M
Rd Expense Q2 2025 · Jun 30, 2025 $7.31M
Rd Expense Q2 2025 · Jun 30, 2024 $2.34M
Rd Expense Q2 2025 · Jun 30, 2024 $4.91M
Net Income Q2 2025 · Jun 30, 2025 −$4.02M
Net Income Q2 2025 · Jun 30, 2025 −$8.46M
Net Income Q2 2025 · Jun 30, 2024 −$2.19M
Net Income Q2 2025 · Jun 30, 2024 −$4.59M
Operating Income Q2 2025 · Jun 30, 2025 −$4.26M
Operating Income Q2 2025 · Jun 30, 2025 −$8.87M
Operating Income Q2 2025 · Jun 30, 2024 −$2.31M
Operating Income Q2 2025 · Jun 30, 2024 −$4.86M